Cost-Effectiveness Analysis of Adjuvant Treatment for Resected Pancreatic Cancer in China Based on the ESPAC-4 Trial
Cancer Management and Research - New Zealand
doi 10.2147/cmar.s172704
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 1, 2018
Authors
Publisher
Informa UK Limited